Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remington

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Investigative Ophthalmology & Visual Science|November 28, 2002
mRNA encoding a new lipolytic enzyme expressed in rabbit lacrimal glandsSusann G Remington, J Daniel Nelson
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1984
The question of lithium/neuroleptic toxicityJ Jeffries, G Remington, J Wilkins
The American Journal of Psychiatry|September 12, 1998
APA Practice Guideline for schizophrenia: risperidone equivalents. American Psychiatric AssociationG Remington, S Kapur, R Zipursky
The British Journal of Psychiatry. Supplement|October 9, 1998
Pharmacotherapy of first-episode schizophreniaG Remington, S Kapur, R B Zipursky
The American Journal of Psychiatry|February 16, 1999
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophreniaS Kapur, R B Zipursky, G Remington
The American Journal of Psychiatry|June 9, 1999
Distinguishing change in primary and secondary negative symptomsG Remington, S A Chong, S Kapur
Journal of Clinical Psychopharmacology|August 1, 1992
Amenorrhea and galactorrhea associated with fluvoxamine in a loxapine-treated patientJ Jeffries, K Bezchlibnyk-Butler, G Remington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 26, 2000
Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the benchS Kapur, M L Wadenberg, G Remington
Psychopharmacology|March 22, 1979
Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenanceH Anisman, G Remington, L S Sklar
European Psychiatry : the Journal of the Association of European Psychiatrists|March 18, 2014
Impact of primary negative symptoms on functional outcomes in schizophreniaG Fervaha, G Foussias, O Agid, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Investigative Ophthalmology & Visual Science|November 28, 2002
mRNA encoding a new lipolytic enzyme expressed in rabbit lacrimal glandsSusann G Remington, J Daniel Nelson
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1984
The question of lithium/neuroleptic toxicityJ Jeffries, G Remington, J Wilkins
The American Journal of Psychiatry|September 12, 1998
APA Practice Guideline for schizophrenia: risperidone equivalents. American Psychiatric AssociationG Remington, S Kapur, R Zipursky
The British Journal of Psychiatry. Supplement|October 9, 1998
Pharmacotherapy of first-episode schizophreniaG Remington, S Kapur, R B Zipursky
The American Journal of Psychiatry|February 16, 1999
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophreniaS Kapur, R B Zipursky, G Remington
The American Journal of Psychiatry|June 9, 1999
Distinguishing change in primary and secondary negative symptomsG Remington, S A Chong, S Kapur
Journal of Clinical Psychopharmacology|August 1, 1992
Amenorrhea and galactorrhea associated with fluvoxamine in a loxapine-treated patientJ Jeffries, K Bezchlibnyk-Butler, G Remington
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 26, 2000
Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the benchS Kapur, M L Wadenberg, G Remington
Psychopharmacology|March 22, 1979
Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenanceH Anisman, G Remington, L S Sklar
European Psychiatry : the Journal of the Association of European Psychiatrists|March 18, 2014
Impact of primary negative symptoms on functional outcomes in schizophreniaG Fervaha, G Foussias, O Agid, et al.
Pageof 10